Plasmablastic pituitary lymphoma in a patient with human immunodeficiency virus: brief review of the literature and clinical case report

Author:

Martynov D. V.1ORCID,Valiev T. T.2ORCID,Odzharova A. A.1ORCID,Ryabukhina Yu. E.3ORCID,Zeynalova P. A.4ORCID,Mikhailova S. N.1ORCID

Affiliation:

1. N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

2. N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University); Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia

3. Clinical Hospital “Lapino” of the “Mother and Child” Group of companies

4. I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University); Clinical Hospital “Lapino” of the “Mother and Child” Group of companies

Abstract

Plasmoblastic lymphoma is a rare, aggressive B-cell malignancy with poor long-term survival. Plasmoblastic lymphoma occurs most commonly in patients infected with human immunodeficiency virus (HIV), but cases associated with solid organ transplantation have also been reported, less commonly plasmoblastic lymphoma registers in immunocompetent patients. The disease is more common in male patients (75 %) aged from 8 to 62 years (median age 50 years), and most often the tumor lesions are localized in the oral cavity. Rare localizations of plasmoblastic lymphoma include pleura, testicles, mammary glands, lungs, and skin. As casuistic areas of lesions, the central nervous system can be noted.The article describes a clinical case of HIV-positive pediatric patient with rare plasmoblastic lymphoma of chiasmosellar zone. The disease was complicated with secondary hypocorticism and hypotyreosis, a deficiency of somatotrophic hormone and diabetes insipidus.

Publisher

Publishing House ABV Press

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3